Marta Kawczyńska is a European Patent Attorney, as well as Polish Patent and Trademark Attorney. She is also professional representative before the European Union Intellectual Property Office (EUIPO) and European Patent Litigator (UPC).
She joined POLSERVICE in 2002. Since 2015 she has been a member of the firm’s Supervisory Board since 2015 and in 2021 she has been elected as the Chair of the firm’s Supervisory Board.
Ms. Kawczyńska specializes in strategic and comprehensive counselling on protection and enforcement of biotechnology, life sciences and pharmaceutical inventions, including developing IP protection strategies, drafting and prosecution of patent applications. Her area of expertise includes also all matters related to supplementary protection certificate applications for medicinal products and plant protection products. Apart from that she is also experienced in patent litigation matters both at a national and international levels. She represents clients before different Polish and international authorities, including the Polish Patent Office, the European Patent Office (EPO), the World Intellectual Property Organization (WIPO) and administrative courts, and through a vast network of international contact before patent offices in other countries. She advises both global companies from pharmaceutical and biotechnology industries, and domestic clients, including universities, technology transfer centers, start-ups and small and medium-sized enterprises.
Since 2015 Ms. Kawczyńska has been a member of the Board of the Polish National Group of the Association for the Protection of Intellectual Property (AIPPI Poland) and currently serves a Vice-President of the AIPPI Poland. Apart from that she is a longtime active member of the AIPPI Standing Committee - Biotechnology, as well as observer in AIPPI Standing Committee – Pharma. Biotech Committee and AIPPI Biotech Committee. She is also a member-observer of AIPPI Pharma and UP/UPC Committee. Further to that since 2017 she has been a Council member of the European Patent Institute (epi) elected for Poland. Additionally, she is a also of the epi’s Committee on Biotechnological Inventions and member of the thematic group Pharma of the epi’s European Patent Practice Committee. Apart from that she is a member of the Polish Chamber of Patent Attorneys (PIRP) and for many years she served as the Council Member of the Mazovian region of the Polish Chamber of Patent Attorneys. Currently she serves as a member of the Chamber’s special committee on the UPC and Examination Committee. She is also a member of the Union of European Practitioners in Intellectual Property. Since October 2024, Ms. Kawczyńska serves as a member of the newly established at the Polish Patent Office Quality Advisory Panel.
Ms. Kawczyńska graduated from the Intercollegiate Faculty of the Medical University of Gdansk and the University of Gdansk, where she specialized in molecular medicine and genetics. She conducted research on the molecular background of different cancers and the development of molecular diagnostic and prognostics tests for some viral and cancer diseases. She completed post-graduate studies on Industrial Property Law at the Law and Administration Faculty of the University of Warsaw, as well as a course on European Patent Law organized by the Centre for International Intellectual Property Studies (CEIPI) at the University of Strasbourg. She also participated in different internships at the EPO in Munich, including an internship at the EPO Technical Boards of Appeal.
Ms. Kawczyńska is a frequent speaker and panelist at IP-related conferences and seminars in Poland and worldwide. She also frequently lectures at the Polish Chamber of Patent Attorneys, in particular on patent drafting techniques to trainee patent and trademark attorneys and UP/UPC matters. She is also a guest lecturer at the Intercollegiate Faculty of Biotechnology of the University of Gdańsk and Medical University of Gdańsk. Additionally, she has authored several IP law related publications, including on UPC matters, and co-authored Wolters Kluwer publications on Antibody Patenting.
